6月16日，国家统计局发布2025年5月份70个大中城市商品住宅销售价格变动情况。2025年5月份，70个 大中城市中，各线城市商品住宅销售价格环比下降，同比降幅继续收窄。 一、各线城市商品住宅销售价格环比下降 5月份，一线城市新建商品住宅销售价格环比由上月持平转为下降0.2%。其中，上海上涨0.7%，北京、 广州和深圳分别下降0.4%、0.8%和0.4%。 5月份，一线城市二手住宅销售价格环比下降0.7%，降幅比上月扩大0.5个百分点。其中北京、上海、广 州和深圳分别下降0.8%、0.7%、0.8%和0.5%。二三线城市二手住宅销售价格环比均下降0.5%，降幅均 扩大0.1个百分点。 二、各线城市商品住宅销售价格同比降幅继续收窄 5月份，一线城市新建商品住宅销售价格同比下降1.7%，降幅比上月收窄0.4个百分点。其中，上海上涨 5.9%，北京、广州和深圳分别下降4.3%、5.8%和2.6%。 二三线城市新建商品住宅销售价格同比分别下降3.5%和4.9%，降幅分别收窄0.4个和0.5个百分 点。 5月份，一线城市二手住宅销售价格同比下降2.7%，降幅比上月收窄0.5个百分点。其中，北京、上海、 广州和深圳分别 ...

2025 年 5 月经济数据点评 5 月经济数据的"五大变数" 2025 年 06 月 16 日 [Table_Author] 分析师：陶川 分析师：张云杰 研究助理：钟渝梅 执业证号：S0100524060005 执业证号：S0100525020002 执业证号：S0100124080017 邮箱：taochuan@mszq.com 邮箱：zhangyunjie@mszq.com 邮箱：zhongyumei@mszq.com ➢ 事件： 6 月 16 日，国家统计局发布 5 月份国民经济运行数据。 ➢ 产业韧性和需求不足是当下经济运行的一体两面，5 月经济所呈现出的"生 产稳、投资软，消费升"，表明二季度仍处于政策的观察期。就总量而言，5 月二 产（工业增加值）和三产（服务业生产指数）增速均在 6%附近，表明二季度 GDP 增速 5%以上基本无虞；但结构来看，关税逆风下行业的冷热不均叠加物价走低， 下半年经济所面临的一些新的"变数"正在显现： ➢ 变数一：消费强于投资能否持续？在今年"贸易摩擦"升温的背景下，消费 的表现相对好于投资。"解构"消费，"以旧换新"等政策支持起到了至关重要的 作用，并与"618" ...

3、深交所公告，港股通标的证券名单发生调整并自2025年06月16日起生效，调入宁德时代。 4、截至午间收盘，沪指涨0.05%，深证成指涨0.13%，创业板指涨0.37%。恒生指数跌0.12%，恒生科技 指数涨0.15%。 1、国家统计局数据显示，5月份规模以上工业增加值同比增长5.8%，1—5月份规模以上工业增加值同 比增长6.3%。1—5月份全国固定资产投资同比增长3.7%。5月份社会消费品零售总额同比增长6.4%，1 —5月份社会消费品零售总额同比增长5.0%。 2、国家统计局数据显示，5月份，70个大中城市中，各线城市商品住宅销售价格环比下降，同比降幅继 续收窄。 智通财经6月16日午间新闻精选 ...

5月份各线城市商品住宅销售价格同比降幅继续收窄 5月份，一线城市二手住宅销售价格环比下降0.7%，降幅比上月扩大0.5个百分点。其中北京、上海、广 州和深圳分别下降0.8%、0.7%、0.8%和0.5%。二、三线城市二手住宅销售价格环比均下降0.5%，降幅 均扩大0.1个百分点。 二、各线城市商品住宅销售价格同比降幅继续收窄 5月份，一线城市新建商品住宅销售价格同比下降1.7%，降幅比上月收窄0.4个百分点。其中，上海上涨 5.9%，北京、广州和深圳分别下降4.3%、5.8%和2.6%。二、三线城市新建商品住宅销售价格同比分别 下降3.5%和4.9%，降幅分别收窄0.4个和0.5个百分点。 ——国家统计局城市司首席统计师王中华解读2025年5月份商品住宅销售价格变动情况统计数据 2025年5月份，70个大中城市中，各线城市商品住宅销售价格环比下降，同比降幅继续收窄。 一、各线城市商品住宅销售价格环比下降 5月份，一线城市新建商品住宅销售价格环比由上月持平转为下降0.2%。其中，上海上涨0.7%，北京、 广州和深圳分别下降0.4%、0.8%和0.4%。二线城市新建商品住宅销售价格环比由上月持平转为下降 0.2% ...

Core Insights - The residential property market in 70 major cities in China shows a mixed trend in new and second-hand housing prices as of May 2025, with some cities experiencing slight declines while others see increases in prices [1][2][3][4][5][6] New Residential Property Prices - In May 2025, the new residential property price index for Beijing is at 99.6 (month-on-month) and 95.7 (year-on-year), indicating a slight decrease compared to the previous month and a significant drop compared to the same month last year [1] - Shanghai's new residential prices increased slightly to 100.7 (month-on-month) and 105.9 (year-on-year), showing resilience in the market [1] - Cities like Shenzhen and Guangzhou show a month-on-month decrease in new residential prices at 99.6 and 99.2 respectively, while year-on-year comparisons also reflect declines [1] Second-Hand Residential Property Prices - The second-hand residential property price index for Beijing stands at 99.2 (month-on-month) and 99.3 (year-on-year), indicating stability but a slight decline from the previous month [3][4] - In contrast, cities like Hangzhou and Nanjing show a month-on-month decrease in second-hand prices at 99.6 and 99.1 respectively, while year-on-year comparisons also reflect declines [3][4] - The overall trend in second-hand residential prices across major cities indicates a more pronounced decline compared to new residential properties, with many cities reporting lower indices [3][4] Price Classification by Size - The price index for new residential properties categorized by size shows that properties under 90m² in Beijing have a month-on-month index of 99.7 and a year-on-year index of 95.8, indicating a decline [5] - For properties between 90-144m², the index in Beijing is at 99.6 (month-on-month) and 95.0 (year-on-year), while properties over 144m² show a similar trend with an index of 99.6 (month-on-month) and 96.0 (year-on-year) [5] - The classification indicates that smaller properties are experiencing a more significant decline compared to larger properties in several cities [5] Regional Variations - Cities like Chengdu and Xi'an show resilience with month-on-month indices of 100.3 and 99.5 respectively, indicating stable or increasing prices [1][5] - Conversely, cities such as Tangshan and Hohhot show declines in both new and second-hand property prices, reflecting regional disparities in the housing market [1][3][5] - The data suggests that while some major cities are stabilizing or increasing in price, others are facing challenges, highlighting the uneven recovery in the residential property market across China [1][3][5]

花旗称，4月以来金价上涨显著缩小了老铺黄金相对大众市场的溢价，提升了其高端产品吸引力，有助 于迅速扩大客户群。花旗表示，若金价维持在当前高位，尽管基数较高，仍预计至2025年下半年老铺黄 金的同店销售增长将维持在三位数；将目标价由979港元上调至1084港元，主要风险为金价波动。 ...

| 指数 | 收盘 | | 涨跌（％） | | | --- | --- | --- | --- | --- | | 名称 | （点） | 1 日 | 5 日 | 1 月 | | 上证指数 | 3377 | -0.75 | 0.06 | -0.25 | | 深证综指 | 2001 | -1.31 | 0.04 | -0.33 | | 风格指数 | 昨日表现 | 1 个月表现 | 6 个月表现 | | --- | --- | --- | --- | | | （％） | （％） | （％） | | 大盘指数 | -0.75 | -1.04 | -1.47 | | 中盘指数 | -0.8 | -0.62 | -6.18 | | 小盘指数 | -1.36 | -0.88 | -2.7 | | 行业涨幅 | 昨日涨 | 1 个月涨 | 6 个月涨 | | --- | --- | --- | --- | | 油服工程 | 6.41 | 11.9 | 4.09 | | 地面兵装Ⅱ | 4.68 | 0.26 | 9.33 | | 贵金属 | 3.9 | 9.5 | 32.64 | | 军工电子Ⅱ | 1.74 | -0.65 ...

Core Viewpoint - AWS is significantly increasing its sales quotas for the Greater China region, with most teams seeing increases of 30%-60%, and some even doubling their quotas. This adjustment comes as a response to underwhelming revenue growth in local operations, particularly in Beijing and Ningxia data centers [2][3]. Group 1 - AWS has updated its 2025 sales quotas for the Greater China region, with increases varying by team, generally between 30%-60%, and some teams reportedly seeing their quotas double [2]. - The typical annual quota increase is around 20%-30%, but this year, adjustments were made mid-year, reflecting a more aggressive approach to revenue targets [2]. - The primary motivation for these changes is to improve revenue figures from the China region, which has been facing challenges in growth and performance [2][3]. Group 2 - In addition to quota increases, AWS's ecosystem teams have been tasked with reducing the proportion of "gray areas," which may further intensify revenue pressures [3]. - Many AWS ecosystem employees are seeking discussions with partners about collaboration opportunities in the China region, although concrete plans are still in development [3].

Core Viewpoint - The rapid growth of online healthcare in China has led to significant issues in the sale of prescription drugs on e-commerce platforms, posing serious risks to consumer safety due to lax regulations and practices [1][5]. Group 1: Prescription Drug Sales Issues - The process for purchasing prescription drugs online is alarmingly simple, with consumers not required to provide medical history or prescriptions, leading to "instant prescriptions" without proper medical evaluation [1][2][3]. - In a practical test, the time taken from consultation to prescription issuance was as short as 10 seconds, highlighting the lack of meaningful interaction between patients and online doctors [2][3]. - Some platforms allow for prescription issuance at any hour, with no restrictions on the timing of orders, further exacerbating the issue of oversight in prescription practices [5]. Group 2: Regulatory Violations - Online platforms are found to be in violation of regulations by displaying prescription drug packaging and information that should not be publicly accessible before prescription approval [6][8]. - Certain platforms promote prescription drugs for uses that exceed their approved indications, misleading consumers and potentially endangering their health [8][10]. - There are instances of products being marketed under names and packaging that closely resemble approved medications, raising concerns about counterfeit drugs and misleading advertising [10][12]. Group 3: Legal Implications - The sale of drugs with altered names and packaging may violate multiple laws, including those against unfair competition and drug management regulations, potentially leading to severe penalties for the sellers [12][13]. - Third-party platforms are urged to enhance their oversight of drug sales to prevent the distribution of unapproved or counterfeit medications, as failure to do so could result in shared liability for regulatory breaches [12].

中国基金报记者 天心 继民商基金遭多家基金公司终止基金代销合作后，又有基金公司官宣与大华银行（中国）有限公司终止代销业务。 今年2月，大华银行（中国）宣布，基于战略性业务调整需要，与富邦华一银行签署协议，将向其转让该行的个人业务，也不再从事基金代销业务。 业内人士分析，基金销售市场加速优胜劣汰，未来或迎来从"销量导向"向"投资者盈利导向"的转型。 基金公司官宣终止与大华银行（中国）代销业务 6月13日，上海东方证券资产管理有限公司发布公告称，经与大华银行（中国）有限公司协商一致，决定自2025年6月13日(含)起，双方终止基金代销业务 合作关系，即自2025年6月13日（含）起停止大华银行办理本公司旗下基金的相关销售业务。本公司旗下基金在大华银行已无保有份额，投资者将无法通 过大华银行办理本公司旗下基金的开户、认购、申购、定期定额投资、转换等业务，大华银行原存量基金份额持有人已转至本公司直销平台进行后续维护 服务。 6月12日，平安基金也发布公告称，自6月13日起终止与大华银行（中国）有限公司的相关销售业务的合作，同时不再受理通过大华银行办理本公司旗下基 金的相关销售业务，投资者将无法通过大华银行办理本公司基 ...